ASP Isotopes (NASDAQ:ASPI) Trading Up 12.1% – Should You Buy?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) were up 12.1% during trading on Monday . The company traded as high as $5.96 and last traded at $6.0310. Approximately 3,404,655 shares traded hands during mid-day trading, a decline of 31% from the average daily volume of 4,923,636 shares. The stock had previously closed at $5.38.

Wall Street Analyst Weigh In

A number of analysts recently commented on ASPI shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Friday, March 27th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Tuesday, April 14th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Stock Up 5.9%

The company has a current ratio of 12.23, a quick ratio of 12.20 and a debt-to-equity ratio of 0.77. The firm has a 50-day simple moving average of $5.08 and a 200 day simple moving average of $6.16.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Friday, April 10th. The company reported ($0.84) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.70). The firm had revenue of $33.32 million for the quarter, compared to analysts’ expectations of $2.03 million. ASP Isotopes had a negative net margin of 734.14% and a negative return on equity of 161.55%.

Insider Buying and Selling at ASP Isotopes

In other news, Director Duncan Moore sold 11,642 shares of ASP Isotopes stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $5.21, for a total value of $60,654.82. Following the completion of the transaction, the director owned 1,044,928 shares of the company’s stock, valued at $5,444,074.88. The trade was a 1.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Heather Kiessling sold 23,124 shares of ASP Isotopes stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $5.48, for a total value of $126,719.52. Following the completion of the transaction, the chief financial officer directly owned 709,376 shares of the company’s stock, valued at approximately $3,887,380.48. This represents a 3.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 90,704 shares of company stock valued at $463,252. 14.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On ASP Isotopes

Large investors have recently modified their holdings of the stock. Quantbot Technologies LP purchased a new position in shares of ASP Isotopes in the 3rd quarter worth about $34,000. BNP Paribas Financial Markets increased its holdings in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares in the last quarter. Stephens Inc. AR bought a new stake in ASP Isotopes in the 1st quarter worth about $44,000. Wealthfront Advisers LLC bought a new stake in ASP Isotopes in the 1st quarter worth about $45,000. Finally, IFP Advisors Inc bought a new stake in ASP Isotopes in the 4th quarter worth about $48,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.